City Therapeutics, Inc. (CTY)
NASDAQ: CTY · Real-Time Price · USD
18.10
-0.88 (-4.64%)
At close: Nov 13, 2026, 4:00 PM EST
18.45
+0.35 (1.93%)
After-hours: Nov 13, 2026, 7:30 PM EST
City Therapeutics Market Cap
City Therapeutics has a market cap or net worth of $900.6 million as of November 13, 2026. It is the 10,538th most valuable company in the world and the 2,286th biggest in the United States.
Market Cap
900.60M
Enterprise Value
788.03M
1-Year Change
n/a
Global Rank
Country Rank
#2,286 United States
Category
ChartMarket Cap Chart
Since the IPO on October 16, 2026, City Therapeutics's market cap has increased from $895.62M to $900.60M, an increase of 0.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 900.60M | -4.64% |
| Nov 12, 2026 | 944.38M | 11.58% |
| Nov 11, 2026 | 846.36M | -13.30% |
| Nov 10, 2026 | 976.23M | 5.09% |
| Nov 9, 2026 | 928.96M | 2.30% |
| Nov 6, 2026 | 908.06M | 6.91% |
| Nov 5, 2026 | 849.35M | 4.02% |
| Nov 4, 2026 | 816.51M | -14.04% |
| Nov 3, 2026 | 949.86M | -8.57% |
| Nov 2, 2026 | 1.04B | 0.82% |
| Oct 30, 2026 | 1.03B | -6.46% |
| Oct 29, 2026 | 1.10B | 2.26% |
| Oct 28, 2026 | 1.08B | 3.79% |
| Oct 27, 2026 | 1.04B | 0.34% |
| Oct 26, 2026 | 1.03B | 0.10% |
| Oct 23, 2026 | 1.03B | - |
| Oct 22, 2026 | 1.03B | 1.66% |
| Oct 21, 2026 | 1.02B | -1.92% |
| Oct 20, 2026 | 1.04B | -2.94% |
| Oct 19, 2026 | 1.07B | 19.22% |
| Oct 16, 2026 | 895.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 927.36M |
| Odyssey Therapeutics | 917.59M |
| Corvus Pharmaceuticals | 897.52M |
| MeiraGTx Holdings | 897.17M |
| Pharming Group | 891.17M |
| Inventiva | 883.90M |
| Immatics | 873.45M |
| Latigo Biotherapeutics | 869.18M |